The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schlüter, D.
Right arrow Articles by Bogdan, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schlüter, D.
Right arrow Articles by Bogdan, C.
The Journal of Immunology, 1999, 162: 3512-3518.
Copyright © 1999 by The American Association of Immunologists

Inhibition of Inducible Nitric Oxide Synthase Exacerbates Chronic Cerebral Toxoplasmosis in Toxoplasma gondii-Susceptible C57BL/6 Mice But Does Not Reactivate the Latent Disease in T. gondii-Resistant BALB/c Mice1

Dirk Schlüter*, Martina Deckert-Schlüter{dagger}, Elke Lorenz{ddagger}, Timothy Meyer*, Martin Röllinghoff{ddagger} and Christian Bogdan2,{ddagger}

* Institut für Medizinische Mikrobiologie und Hygiene, Universitätsklinikum Mannheim, Universität Heidelberg, Germany; {dagger} Institut für Neuropathologie, Universitätskliniken Bonn, Bonn, Germany; and {ddagger} Institut für Klinische Mikrobiologie, Immunologie und Hygiene, Universität Erlangen, Erlangen, Germany

Infection of C57BL/6 mice with Toxoplasma gondii leads to progressive and ultimately fatal chronic Toxoplasma encephalitis (TE). Genetic deletion or inhibition of inducible nitric oxide synthase (iNOS) from the beginning of infection increased the number of T. gondii cysts in the brain and markedly reduced the time-to-death in this mouse strain. In the present study, we addressed whether iNOS also contributes to the control of intracerebral parasites in a clinically stable latent infection that develops in T. gondii-resistant BALB/c mice after resolution of the acute phase of TE. iNOS was expressed in the inflammatory cerebral infiltrates of latently infected BALB/c mice, but the number of iNOS+ cells was significantly lower than in the brains of chronically infected T. gondii-susceptible C57BL/6 mice. In BALB/c mice with latent TE (>30 days of infection), treatment with the iNOS inhibitors L-N6-iminoethyl-lysine or L-nitroarginine-methylester for <=40 days did not result in an increase of the intracerebral parasitic load and a reactivation of the disease, despite the presence of iNOS-suppressive inhibitor levels in the brain. However, L-nitroarginine-methylester treatment had remarkably toxic effects and induced a severe wasting syndrome with high mortality. In contrast to BALB/c mice, L-N6-iminoethyl-lysine treatment rapidly exacerbated the already established chronic TE of C57BL/6 mice. Thus, the containment of latent toxoplasms in T. gondii-resistant BALB/c mice is independent of iNOS, whereas the temporary control of intracerebral parasites in T. gondii-susceptible C57BL/6 mice with chronic TE requires iNOS activity.




This article has been cited by other articles:


Home page
Infect. Immun.Home page
H. M. Ibrahim, H. Bannai, X. Xuan, and Y. Nishikawa
Toxoplasma gondii Cyclophilin 18-Mediated Production of Nitric Oxide Induces Bradyzoite Conversion in a CCR5-Dependent Manner
Infect. Immun., September 1, 2009; 77(9): 3686 - 3695.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Drogemuller, U. Helmuth, A. Brunn, M. Sakowicz-Burkiewicz, D. H. Gutmann, W. Mueller, M. Deckert, and D. Schluter
Astrocyte gp130 Expression Is Critical for the Control of Toxoplasma Encephalitis
J. Immunol., August 15, 2008; 181(4): 2683 - 2693.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Zimmermann, P. J. Murray, K. Heeg, and A. H. Dalpke
Induction of Suppressor of Cytokine Signaling-1 by Toxoplasma gondii Contributes to Immune Evasion in Macrophages by Blocking IFN-{gamma} Signaling
J. Immunol., February 1, 2006; 176(3): 1840 - 1847.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. Rozenfeld, R. Martinez, S. Seabra, C. Sant'Anna, J. G. R. Goncalves, M. Bozza, V. Moura-Neto, and W. De Souza
Toxoplasma gondii Prevents Neuron Degeneration by Interferon-{gamma}-Activated Microglia in a Mechanism Involving Inhibition of Inducible Nitric Oxide Synthase and Transforming Growth Factor-{beta}1 Production by Infected Microglia
Am. J. Pathol., October 1, 2005; 167(4): 1021 - 1031.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Duleu, P. Vincendeau, P. Courtois, S. Semballa, I. Lagroye, S. Daulouede, J.-L. Boucher, K. T. Wilson, B. Veyret, and A. P. Gobert
Mouse Strain Susceptibility to Trypanosome Infection: An Arginase-Dependent Effect
J. Immunol., May 15, 2004; 172(10): 6298 - 6303.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. Rozenfeld, R. Martinez, R. T. Figueiredo, M. T. Bozza, F. R. S. Lima, A. L. Pires, P. M. Silva, A. Bonomo, J. Lannes-Vieira, W. De Souza, et al.
Soluble Factors Released by Toxoplasma gondii-Infected Astrocytes Down-Modulate Nitric Oxide Production by Gamma Interferon-Activated Microglia and Prevent Neuronal Degeneration
Infect. Immun., April 1, 2003; 71(4): 2047 - 2057.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
L. C. Gavrilescu and E. Y. Denkers
IFN-{{gamma}} Overproduction and High Level Apoptosis Are Associated with High but Not Low Virulence Toxoplasma gondii Infection
J. Immunol., July 15, 2001; 167(2): 902 - 909.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
Y. R. Freund, N. T. Zaveri, and H. S. Javitz
In Vitro Investigation of Host Resistance to Toxoplasma gondii Infection in Microglia of BALB/c and CBA/Ca Mice
Infect. Immun., February 1, 2001; 69(2): 765 - 772.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.